n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Heart Disease, Ischemic in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaud, C | 1 |
| Joyeux-Faure, M | 1 |
| Godin-Ribuot, D | 1 |
| Ribuot, C | 1 |
| Shibata, R | 1 |
| Sato, K | 1 |
| Pimentel, DR | 1 |
| Takemura, Y | 1 |
| Kihara, S | 1 |
| Ohashi, K | 1 |
| Funahashi, T | 1 |
| Ouchi, N | 1 |
| Walsh, K | 1 |
| Birkenmeier, K | 1 |
| Staudt, A | 1 |
| Schunck, WH | 1 |
| Janke, I | 1 |
| Labitzke, C | 1 |
| Prange, T | 1 |
| Trimpert, C | 1 |
| Krieg, T | 1 |
| Landsberger, M | 1 |
| Stangl, V | 1 |
| Felix, SB | 1 |
| Shinmura, K | 1 |
| Tang, XL | 1 |
| Wang, Y | 1 |
| Xuan, YT | 1 |
| Liu, SQ | 1 |
| Takano, H | 1 |
| Bhatnagar, A | 1 |
| Bolli, R | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Heart Disease, Ischemic
| Article | Year |
|---|---|
COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.
Topics: Animals; Blotting, Western; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2003 |
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Apoptosis; Cells, Cultured; Cyclooxygenase 2; C | 2005 |
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia.
Topics: Adenosine Triphosphate; Animals; Calcium Signaling; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenas | 2007 |
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2000 |